Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

Allucent has strategically added executives to its C-suite and is deploying artificial intelligence tools to help small and ...

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.

One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical ...

Via well-designed AI tools and workflows, trial sponsors are aiming to unify cross-functional data ecosystems to enable a ...

Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

Trial sponsors are typically responsible for providing the experimental drug or treatment at no cost to patients. However, ...

Background Extensions to Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) and Consolidated Standards of Reporting Trials (CONSORT) reporting recommendations specifically for ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the pharmaceutical industry's impact on healthcare.

Cancer clinical trials development in Latin America underperforms globally yet strengths could expand equitable evidence worldwide. A review of the current landscape argues that Latin America, despite ...